Brief: Cardiol Therapeutics Inc - Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
20/10/2023 22:02
Oct 20 (Reuters) - Cardiol Therapeutics Inc CRDL.TO :
* CARDIOL THERAPEUTICS INC - RECEIVES NASDAQ DEFICIENCY
NOTICE
REGARDING MINIMUM BID PRICE REQUIREMENT
Source text for Eikon: ID:
Further company coverage: CRDL.TO
Recent news on Cardiol Therapeutics
See all newsBrief: Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead Of Schedule And Expands Pivotal Trial To Strengthen Assessment Of Cardiolrx's Efficacy
Brief: Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus
Brief: Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln
Brief: Cardiol Therapeutics Initiated Pivotal Phase Iii Maveric Trial Of Cardiolrx In Recurrent Pericarditis
NASDAQ RESUMED AT 09:00 AM